12:00 AM
 | 
Aug 01, 2011
 |  BC Week In Review  |  Company News  |  Deals

MorphoSys, Dana-Farber Cancer Institute deal

MorphoSys' AbD Serotec research and diagnostic antibodies unit granted the institute rights to use Slonomics technology from MorphoSys' Sloning BioTechnology GmbH subsidiary. The institute is conducting research on a...

Read the full 124 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >